Navigation Links
HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council
Date:10/4/2010

BRANFORD, Conn., Oct. 4 /PRNewswire/ -- HistoRx was recognized as a 2010 Company to Watch by the Connecticut Technology Council at the Innovation Pipeline Awards ceremony last week in New Haven, Connecticut.  HistoRx was recognized for significant milestones achieved in 2010:

  • launching its proprietary AQUA® technology software on a second hardware platform -- the ScanScope FL from Aperio
  • signing a licensing deal with a national oncology reference lab for AQUA technology and several diagnostic assays based on it -- Genoptix Medical Laboratory (Nasdaq: GXDX)
  • receiving a U.S. patent for an application of AQUA technology to personalized medicine -- methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers, specifically thymidylate synthase (TS)

These achievements represent key indicators of the company's maturation from a life science technology company to a diagnostics developer nearing first clinical use of its products.

The Innovation & Entrepreneurship Summit is a juried event designed to showcase the products and services from approximately 100 exciting early stage companies in various advanced technology categories.  Each year the event draws several hundred investors, corporate business development executives, prospective customers and the media.  This multifaceted event included a technology showcase of the award-winning Companies to Watch, and focused on young, emerging technology companies with an innovative product or service and the potential to grow quickly.

The Connecticut Technology Council is a statewide association of technology oriented companies and institutions, providing leadership in areas of policy advocacy, community building and assistance for growing companies.  Speaking for over 2,000 companies that employ some 200,000 residents, the Connecticut Technology Council seeks to provide a strong and urgent voice in support of the creation of a culture of innovation.

HistoRx, Inc. is a leading developer of tissue-based theranostic solutions to advance individualized patient care.  The Company's products and services are based on proprietary AQUA® technology for tissue biomarker analysis.  AQUA® software is the only platform capable of precisely measuring protein biomarker concentration with sub-cellular resolution in tissue sections, enabling fully objective, standardized, reproducible, and automated analysis to guide targeted drug development and therapeutic decision making.  HistoRx currently helps biopharmaceutical companies advance their product pipelines by generating valuable new insights into the safety and effectiveness of targeted therapeutics in development for cancer and other diseases, and is developing clinical assays based on these insights.  The first clinical diagnostics based on AQUA® technology will be launched in late 2010.  For more information please visit:  www.historx.com.


'/>"/>
SOURCE HistoRx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. FreshFx Recognized for use in the Scalder as a Solution to the Yield/Pathogen Reduction Dilemma
3. Corgenix AspirinWorks(R) Test Recognized in POLYCAP Study at ACC.09
4. invivodata Recognized as One of Pittsburghs Fastest Growing Private Companies
5. Roche Scientist Recognized for Excellence in Peptide Chemistry
6. SEI Defined Benefit Client Recognized With Leading Plan Design Award
7. Nonin Medical Recognized for Influential Contributions in Medical Technology
8. China Sky One Medical, Inc.s AMI Diagnostic Kit Recognized as a National Innovation Project by NDRC
9. AQUA(R) Technology Recognized as Promising New Strategy for Hormone Receptor Testing in Breast Cancer by NCCN Task Force
10. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
11. Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & Associates ... special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to date ... elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded by ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
Breaking Medicine News(10 mins):